ClinicalTrials.gg
Not yet recruitingNCT07814989RA: rheumatoidUpdated Sep 11, 2026

Wrist Nerve Block as a New Treatment in Patients With Rheumatoid Arthritis

An interventional study of Wrist local steroid injection in Rhematoid Arthritis, sponsored by Sohag University. Not yet recruiting at 1 site in Egypt. Open to participants aged 16 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-09-11.

Sponsored by Sohag University · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
180
Allocation
Non-randomized
Ages
16 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 20 studies in Arthritis, Rheumatoid by Sohag University — 10 open to participants now, 11 under way, 1 of them phase 3. Arthritis, Rheumatoid · Sohag University.

Started
2026
with 5 others
No phase
7 of 20
2 open now
Primary completion
2027-01
later than 5 of 10 live
Registered
18th of 20
by date

Among the 20 studies in Arthritis, Rheumatoid by Sohag University, this one is one of 6 that started in 2026, is one of 7 with no phase, reaches primary completion later than 5 of the 10 other live ones, and was the 18th registered.

Arthritis, Rheumatoid

3,339 studies on the registry are indexed under Arthritis, Rheumatoid; 446 are open to participants now.

Browse Arthritis, Rheumatoid studies →

Open to participants now

10 of the 20 studies in Arthritis, Rheumatoid by Sohag University are open now, in 1 country. Recruiting first, the newest first:

4 more — sign in →

By country, each count listing its studies:

All 10 open studies →

Where they have run

Who these studies take

Of the 293 Arthritis, Rheumatoid studies recruiting now, 151 (52%) set no upper age limit and 109 (37%) stop at 75 or younger; 15 take children under 18; 36 take healthy volunteers.

This study: 16 Years to 60 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 20 studies in Arthritis, Rheumatoid by Sohag University, or all of them as a file.
02

Study summary

Rheumatoid arthritis is a chronic, systemic, autoimmune inflammatory disease that mainly affects the joints and periarticular soft tissues.[1]

03

Conditions studied

  • Rhematoid Arthritis

Keywords

  • Rheumatoid Arthritis
  • Nerve block
  • Wrist injection
04

Who can participate

Ages eligible
16 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. RA patients fulfilled the 2010 American College of Rheumatoid Arthritis classification criteria.[8]
  2. Oligoarticular RA patients including wrist joint.
  3. Age above 18 years old.
  4. Patient cooperative and can answer questions.

Exclusion criteria

Exclusion Criteria:

  1. Other rheumatologic or collagen diseases.
  2. Age below 18 years.
  3. Patients who underwent concomitant procedures to address underlying pathology such as radial styloidectomy, ulna shortening, fracture fixation, arthroplasty, arthrodesis, and ligament reconstructions.
  4. Patients who suffered from hand deformities or limitation.
  5. Uncooperative patients.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
180 participants (estimated)

Study arms

  • Active comparator
    Group 1

    wrist nerve block

    Procedure: Wrist local steroid injection

  • Placebo comparator
    Group 2

    wrist local steroid injection

    Procedure: Wrist local steroid injection

  • No intervention
    Group 3

Interventions

  • ProcedureWrist local steroid injection

    Wrist nerve block by injection is a diagnostic or therapeutic procedure used to treat chronic wrist pain, typically arising from arthritis or instability, by interrupting sensory nerve signals (mainly PIN/AIN nerves) with an anesthetic or neurolytic agent. This less-invasive approach provides pain relief, often serving as a predictor for success before permanent surgical denervation.\[4\]

06

What researchers measure

Primary outcomes

  1. Change in wrist pain severity measured by the Visual Analogue Scale (VAS) from baseline to Week 16

    Change in wrist pain severity measured using the Visual Analogue Scale (VAS) from baseline to Week 16 Visual Analogue Scale (VAS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Wrist pain severity will be assessed using the Visual Analogue Scale (VAS), ranging from 0 to 10, where 0 represents no pain and 10 represents the worst imaginable pain. Higher scores indicate greater pain. The change in VAS score from baseline to Week 16 will be assessed.

    Time frame: Baseline to Week 16

  2. Assessment of wrist pain improvement

    • Change in wrist pain severity measured by the Visual Analogue Scale (VAS) from baseline to Week 16

    Time frame: 16 weeks

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Aug 2026; primary completion for Jan 2027, 4 months later.

Of 293 non-industry interventional studies with no phase under Arthritis, Rheumatoid, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 39. This study's planned 4 months is below that.

Counting every sponsor, half of 349 studies reached it within 27 months; a quarter within 13 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 30, 2026
First posted
Sep 11, 2026
StartEst.
Aug 15, 2026
Primary completionEst.
Jan 1, 2027
CompletionEst.
Jul 1, 2027
Last update
Sep 11, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07814989
Lead sponsor
Sohag University
Responsible party
Yousra Aly Lamie (Resident, Sohag University) — Principal investigator
First posted
Sep 11, 2026
Start date
Aug 15, 2026 (estimated)
Primary completion
Jan 1, 2027 (estimated)
Completion
Jul 1, 2027 (estimated)
Last update
Sep 11, 2026

Study contacts

Youssra Ali Resident
Contact
youssralam3ie@gmail.com
00201122040682
Ahmed mahrous elsamman
Contact
00201122040682

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion